Pyridinium, 3-hydroxy-1-methyl-, bromide, dimethylcarbamate
101-26-8CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]VNYBTNPBYXSMOO-UHFFFAOYSA-MSee also: Pyridostigmine Bromide (preferred); Pyridostigmine (has active moiety).
101-26-8Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
BeschreibungPyridostigmine is an inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE; IC50s = 0.35 and 1 μM, respectively, for the human enzymes). Pyridostigmine (10 μM) reduces decreases in AChE activity induced by the organophosphate pesticides diisopropyl fluorophosphate, chlorpyrifos-oxon, diazinon-oxon, paraoxon, and malaoxon in isolated bovine red blood cells. It also reduces soman-induced membrane depolarization and decreases in AChE activity in isolated human muscle bundles in a concentration-dependent manner. Pyridostigmine (3 mg/kg per day for four weeks) prevents tachycardia and increases in sympathetic tone in mice following myocardial infarction induced by left coronary artery ligation. Formulations containing pyridostigmine have been used in the treatment of myasthenia gravis and as neuromuscular protective agents against organophosphate poisoning.
VerwendenCholinergic, used in the treatment of myasthenia gravis, and is a pre-exposure antidote to chemical warfare agents.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…